ERD

Maxima Butterfly | From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network

01-01-2023

-

31-12-2027

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

01-01-2017

-

31-12-2023

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

ChiLTERN | Children’s Liver Tumour European Research Network

01-01-2016

-

31-12-2021

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

IntReALL 2020 | International Study for Treatment of Childhood Relapsed ALL 2020

01-05-2023

-

30-04-2028

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

iPC | individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology

01-01-2019

-

30-11-2023

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

MELCAYA | Novel health care strategies for melanoma in children, adolescents and young adults

01-12-2022

-

30-11-2026

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

MONALISA | A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis

01-01-2024

-

31-12-2028

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

PanCareSurPass | PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors

01-03-2021

-

28-02-2025

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

AiPBAND | An Integrated Platform for Developing Brain Cancer Diagnostic Techniques

01-01-2018

-

30-06-2022

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

PanCareFollowUp | PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

01-01-2019

-

31-12-2023

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

HCA Organoid | HCA|Organoid: Pilot action to establish a multi-tissue human organoid platform within the Human Cell Atlas as a booster of future disease-centric, mechanistic, and translational research

01-01-2020

-

30-09-2022

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

VAGABOND | Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students

01-12-2020

-

30-11-2024

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

diaRNAgnosis | A novel platform for the direct profiling of circulating cell-free ribonucleic acids in biofluids

01-01-2021

-

31-05-2025

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

TREL | Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania

01-01-2021

-

31-12-2023

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

Dypha | Dypha: adding the dimension of time to cell culture

01-04-2024

-

31-03-2027

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

SCARLET | Scaling up early and late effects research in Lithuanian childhood cancer survivors through education and twinning

01-10-2024

-

30-09-2027

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

GlycoMap | Integrated Glycomics for Cancer Precision Medicine

01-09-2023

-

31-08-2025

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

RESTART | How is blood (re-)made? Regeneration of human hematopoietic stem cells after transplantation

01-01-2024

-

31-12-2028

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

DynaMech | Linking Transcription Factor Binding Dynamics to Promoter Output

01-02-2016

-

31-01-2021

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

RhabdoEvo | Deciphering the cellular origin and evolution of malignant rhabdoid tumors

01-12-2019

-

31-05-2025

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

PREDICT | PREcision medicine Drug combination testing In neuroblastoma organoids to guide Clinical Trials

01-03-2017

-

28-02-2022

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

CANCER INVASION | Deciphering and targeting the invasive nature of Diffuse Intrinsic Pontine Glioma

01-01-2019

-

31-12-2023

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

SecondCANCERinKIDS | What causes therapy-related malignancies in childhood cancer survivors? Dissecting the etiology of second cancers

01-04-2020

-

31-03-2025

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

FINDR | Spatiotemporal characterization of extrachromosomal DNA transcription and its key regulators in cancer cells

01-04-2024

-

31-03-2026

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

MUTAPREDICT | Benchmarking AI to predict mutagenicity by combing chemical structure and genome-wide mutation data

01-10-2024

-

31-03-2026

Show more information

Organisation PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

Projects overview

Selected filters:

Maxima Butterfly | From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network

ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

ChiLTERN | Children’s Liver Tumour European Research Network

IntReALL 2020 | International Study for Treatment of Childhood Relapsed ALL 2020

iPC | individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology

MELCAYA | Novel health care strategies for melanoma in children, adolescents and young adults

MONALISA | A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis

PanCareSurPass | PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors

AiPBAND | An Integrated Platform for Developing Brain Cancer Diagnostic Techniques

PanCareFollowUp | PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

HCA Organoid | HCA|Organoid: Pilot action to establish a multi-tissue human organoid platform within the Human Cell Atlas as a booster of future disease-centric, mechanistic, and translational research

VAGABOND | Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students

diaRNAgnosis | A novel platform for the direct profiling of circulating cell-free ribonucleic acids in biofluids

TREL | Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania

Dypha | Dypha: adding the dimension of time to cell culture

SCARLET | Scaling up early and late effects research in Lithuanian childhood cancer survivors through education and twinning

GlycoMap | Integrated Glycomics for Cancer Precision Medicine

RESTART | How is blood (re-)made? Regeneration of human hematopoietic stem cells after transplantation

DynaMech | Linking Transcription Factor Binding Dynamics to Promoter Output

RhabdoEvo | Deciphering the cellular origin and evolution of malignant rhabdoid tumors

PREDICT | PREcision medicine Drug combination testing In neuroblastoma organoids to guide Clinical Trials

CANCER INVASION | Deciphering and targeting the invasive nature of Diffuse Intrinsic Pontine Glioma

SecondCANCERinKIDS | What causes therapy-related malignancies in childhood cancer survivors? Dissecting the etiology of second cancers

FINDR | Spatiotemporal characterization of extrachromosomal DNA transcription and its key regulators in cancer cells

MUTAPREDICT | Benchmarking AI to predict mutagenicity by combing chemical structure and genome-wide mutation data